Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04406584 · ClinicalTrials.gov registry record · NA
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04406584: Completed NA study, sponsored by Stanford University.
NCT04406584 is a NA study that has completed, run by Stanford University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04406584, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This randomized clinical trial will evaluate the benefit of platelet-rich plasma (PrP) in the treatment of olfactory dysfunction. PrP can be isolated from a patient's own blood and has been found in previous studies to have anti-inflammatory and pro-regenerative properties. It has been used across multiple specialties, such as Orthopedics, Facial Plastics, Dermatology, Neurology in injected form to treat a wide variety of tissues to encourage the body's inherent regenerative capacity. The investigators have completed a pilot study here evaluating it's use in olfactory loss which demonstrated safety and also suggested efficacy. Therefore, the investigators aim to assess the ability of PrP to improve olfactory function in patients with decreased sense of smell.
Interventions
- PROCEDURE Injection into olfactory cleft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-22 |
| Est. Completion | 2022-08-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04406584
The ClinicalTrials.gov registry entry for NCT04406584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Injection into olfactory cleft is the first listed.
NCT04406584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04406584 about?
NCT04406584 is a clinical study titled "Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction". This randomized clinical trial will evaluate the benefit of platelet-rich plasma (PrP) in the treatment of olfactory dysfunction. PrP can be isolated from a patient's own blood and has been found in previous studies to have anti-inflammatory and pro-regenerative properties. It has been used across m...
What is the current status of trial NCT04406584?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-06-22. Estimated completion is 2022-08-11.
What interventions are being tested in trial NCT04406584?
The interventions under investigation include: Injection into olfactory cleft (PROCEDURE).
Who is sponsoring clinical trial NCT04406584?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.